AI-based Classifiers for Lung Cancer Subtyping Findings Presented
The results of AI-based classifiers for lung cancer using Qlucore Insights were recently presented by researchers.
Read MorePosted by Chris Wolski | Dec 20, 2024 | Lung Cancer |
The results of AI-based classifiers for lung cancer using Qlucore Insights were recently presented by researchers.
Read MorePosted by Andy Lundin | Dec 16, 2024 | Leukemia |
Researchers developed a groundbreaking blood test to personalize nanomedicine therapies for leukemia patients, improving treatments.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Lung Cancer, Molecular Diagnostics |
NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Leukemia, Sequencing Systems |
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Flow Cytometry, Leukemia |
A new diagnostic classification module for AHEAD Medicine’s Cyto-Copilot platform enhances AML versus non-neoplastic classification.
Read More